AI & Technology

The $16.6 trillion in assets incorporating Environmental, Social and Governance (ESG) criteria represent a nearly 43 percent increase over the $11.6 trillion in such assets identified in 2018.

Sustainable investing in the US continues to expand at a very healthy pace.

Reflecting its ongoing commitment to global decarbonization and further advancing efforts to create a more balanced energy portfolio, Black & Veatch announces that it has joined the Hydrogen Council, “a global initiative of leading energy, transport and industry companies with a united vision and long-term ambition for hydrogen to foster the energy transition.”

Keysight executives comment on the shape-shifting business operations and technology trends that are unfolding through the lens of the pandemic, the effects of which will continue to have lasting effects on organizations and society.

As the old saying goes, if you don’t have your health, you don’t have anything. At Tetra Tech, we use our Leading with Science® approach every day to support healthy people, healthy communities, and healthy environments.

Cummins Inc. (NYSE: CMI) and Purdue University are partnering on a pilot workforce development program, Indiana Digital Crossroads, as an initiative to address regional workforce challenges in technology-based fields.

I don’t remember in my lifetime a year of change that compares with 2020. It is impacting every aspect of our daily lives – work, play, health, social interaction, economics, travel and tourism, politics, racial and social unrest.

IBM AI Education is an immersive, online professional learning suite of FREE live and on-demand webinars taken to the next level, crafted by and for educators.

The Plastics Recovery Insight and Steering Model ("PRISM") will aim to serve as a single source of consistent actionable data helping inform how NGOs, communities, regulators and other organizations, improve waste management decisions and programs.

Within the next few years, temperature-sensitive biopharmaceutical products such as biologics, drugs, vaccines, and blood products are expected to be used at approximately twice the rate of other pharmaceutical products.